Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 32: 2079-2082, 1986;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsao, D.
Right arrow Articles by Lee, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsao, D.
Right arrow Articles by Lee, S. D.

Clinical Chemistry, Vol 32, 2079-2082, Copyright © 1986 by American Association for Clinical Chemistry

Two-site enzyme immunoassay for alpha-fetoprotein in dried-blood samples collected on filter paper

D Tsao, KJ Hsiao, JC Wu, CK Chou and SD Lee

This is a method for measuring alpha-fetoprotein (AFP) in eluates of dried-blood samples on filter paper by use of a simple, sensitive two- site enzyme immunoassay. The spot, 6 mm in diameter (equivalent to about 12 microL of whole blood), is incubated overnight with alkaline phosphatase conjugated to rabbit anti-AFP antibody in a tube containing a polystyrene bead coated with mouse monoclonal antibody to AFP. After the beads are washed the enzyme activities associated with them are determined colorimetrically, with p-nitrophenyl phosphate as substrate. The measurable range of AFP is from 9 to 900 micrograms per liter of plasma. AFP in the dried-blood spot as determined by this method correlated well with the AFP value for serum from the same blood sample as determined by radioimmunoassay (r = 0.957, p less than 0.001). Preliminary studies in which we used this method with 242 healthy blood donors and 60 patients with hepatocellular carcinoma indicate that it may be suitable for use in mass screening for hepatocellular carcinoma in high-risk populations.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Association for Clinical Chemistry.